🔴 Inovio Pharmaceuticals is trading 5.6% down today in pre-market amid Nasdaq's 1.55% drop

Inovio Pharmaceuticals is trading 5.6% down at $1.18 after opening pre-market below the September 11 close of $1.25, amid broad market weakness.

• No fresh company-specific announcement or earnings release was identified for September 14, 2026; recent coverage centers on the October 30 FDA decision for INO-3107.
• Weaker pre-market risk sentiment includes a 1.55% Nasdaq drop, higher oil prices, elevated Treasury yields and renewed geopolitical concerns.
• Confidence is medium because company-specific coverage is limited.